IDEX Stock Gains From Business Strength, Headwinds Persist
Werte in diesem Artikel
IDEX Corporation IEX is benefiting from solid momentum in the Fluid & Metering Technologies segment. Persistent strength in the intelligent water business, driven by solid demand in the North American municipal market, bodes well for the segment. The segment’s organic revenues increased 3% on a year-over-year basis in the fourth quarter of 2024. Driven by the favorable trend in its business, the company anticipates overall organic revenues to increase 1-3% year over year in 2025.The company intends to strengthen and expand its businesses through buyouts. In September 2024, IDEX acquired Mott Corporation and its subsidiaries (Mott) for $1 billion. This acquisition expanded the company’s applied materials science technology capabilities and strengthened its micro-precision technology offerings in key markets such as semiconductor fabrication, medical technologies and water purification.Also, in December 2023, IEX closed the buyout of advanced material science solutions provider STC Material Solutions for $206 million. This buyout expanded the company’s growing expertise in the material sciences space. In the fourth quarter of 2024, acquisitions had a positive impact on sales of 6%.Management remains focused on rewarding its shareholders through dividend payouts and share buybacks. For instance, in 2024, IDEX paid dividends worth $205.3 million, an increase of 7.7% year over year. Also, it hiked its quarterly dividend rate by 7.8% in May 2024.IEX’s Price PerformanceImage Source: Zacks Investment ResearchIn the past month, the Zacks Rank #3 (Hold) company has lost 3.9% compared with the industry’s 6% decline.However, IDEX is grappling with weakness in the Health & Science Technologies segment due to a lower demand environment across the life sciences, analytical instrumentation, automotive and semiconductor capital equipment markets. In 2024, the segment’s organic revenues declined 7% year over year and were flat in the fourth quarter.Rising selling, general and administrative expenses are a threat to IDEX’s bottom line. The metric grew 14% year over year in the fourth quarter of 2024. Increasing amortization expenses and professional services and discretionary spending are raising its expenses. As a percentage of sales, the metric increased 90 bps year over year to 22.9% in the same period. This upward trajectory follows a pattern of expense growth in the preceding three quarters, with increases of 10.3%, 4.9% and 2.9%, respectively. Also, the company’s cost of sales recorded an increase of 9.7% year over year in the fourth quarter.Stocks to ConsiderSome better-ranked companies are discussed below.DNOW INC DNOW currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.DNOW delivered a trailing four-quarter average earnings surprise of 30.4%. In the past 60 days, the Zacks Consensus Estimate for DNOW’s 2025 earnings has increased 10.2%.Dover Corporation DOV presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 5.3%.In the past 60 days, the consensus estimate for DOV’s 2025 earnings has increased 1.1%.Applied Industrial Technologies, Inc. AIT presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 5.3%.The Zacks Consensus Estimate for AIT’s fiscal 2025 earnings has improved 1.3% in the past 60 days.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dover Corporation (DOV): Free Stock Analysis Report Applied Industrial Technologies, Inc. (AIT): Free Stock Analysis Report IDEX Corporation (IEX): Free Stock Analysis Report DNOW Inc. (DNOW): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: IDEX und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf IDEX
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IDEX
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu IDEX Corp.
Analysen zu IDEX Corp.
Datum | Rating | Analyst | |
---|---|---|---|
16.01.2018 | IDEX Hold | Stifel, Nicolaus & Co., Inc. | |
18.10.2017 | IDEX Sector Perform | RBC Capital Markets | |
27.07.2017 | IDEX Sector Perform | RBC Capital Markets | |
21.04.2017 | IDEX Hold | Stifel, Nicolaus & Co., Inc. | |
21.04.2017 | IDEX Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.01.2018 | IDEX Hold | Stifel, Nicolaus & Co., Inc. | |
21.04.2017 | IDEX Hold | Stifel, Nicolaus & Co., Inc. | |
19.10.2016 | IDEX Hold | Stifel, Nicolaus & Co., Inc. | |
08.04.2016 | IDEX Market Perform | BMO Capital Markets | |
25.11.2014 | IDEX Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
18.10.2017 | IDEX Sector Perform | RBC Capital Markets | |
27.07.2017 | IDEX Sector Perform | RBC Capital Markets | |
21.04.2017 | IDEX Sector Perform | RBC Capital Markets | |
07.12.2016 | IDEX Sector Perform | RBC Capital Markets | |
02.10.2012 | IDEX perform | Oppenheimer & Co. Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IDEX Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen